Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725) |
---|
03/03/2004 | EP1392284A2 Methods of treating hyperlipidemia |
03/03/2004 | EP1392283A1 Substituted coumarins and quinolines as caspases activators |
03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
02/26/2004 | WO2003006425A9 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
02/25/2004 | EP1390344A2 Organic compounds |
02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
02/19/2004 | US20040033317 Surface-active photoinitators |
02/17/2004 | US6692657 Alkenyl compound with 2,3-difluorophenyl group |
02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
02/11/2004 | CN1474803A Novel amide derivatives and medicinal use thereof |
02/05/2004 | WO2004011557A1 Functional fluorescent dyes |
02/05/2004 | WO2003074475A3 Substituted aryl ketones |
02/04/2004 | CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
02/03/2004 | US6686350 Cell adhesion inhibitors |
01/29/2004 | WO2004009577A1 Heterodiamondoids |
01/29/2004 | US20040016906 Difluoromethyl ether derivative and process for producing the same |
01/29/2004 | US20040016370 Coatings, films, circuit board |
01/29/2004 | CA2492857A1 Heterodiamondoids |
01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
01/27/2004 | US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms |
01/22/2004 | WO2004007531A2 Activated checkpoint therapy and methods of use thereof |
01/22/2004 | US20040014988 Salt formation with lithium hydroxide in a solvent mixture, comprises aromatic hydrocarbon toluene and methanol, improving filtration, separation |
01/22/2004 | CA2492772A1 Activated checkpoint therapy and methods of use thereof |
01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
01/15/2004 | US20040010143 Viricides |
01/15/2004 | US20040009999 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
01/14/2004 | EP1380580A1 An improved process for the production of subsituted thioxanthones |
01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
01/13/2004 | US6677460 Aromatic carboxylic acid bicyclic sulfur compounds |
01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
01/08/2004 | US20040004207 Difluoromethyl ether derivative and process for producing the same |
01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
01/02/2004 | EP1373195A2 Quaternary amino acids on solid supports |
01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
01/01/2004 | US20040002491 Melatonergic receptors |
01/01/2004 | US20040002490 Melatonergic receptors |
01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
12/31/2003 | WO2004000889A2 Polymeric photoinitiators |
12/31/2003 | WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
12/31/2003 | CN1132831C 液体噻吨酮光引发剂 Liquid thioxanthone photoinitiators |
12/31/2003 | CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
12/30/2003 | US6670358 Substituted thioacetamides |
12/25/2003 | US20030236425 Ultraviolet radiation curable hot melt pressure sensitive adhesives, coatings and casings |
12/25/2003 | US20030236421 Aromatic carboxylic acid bicyclic sulfur compounds |
12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
12/25/2003 | US20030236253 Gabapentin; antiepileptic agents, analgesics |
12/25/2003 | US20030236167 Novel herbicides |
12/25/2003 | US20030235779 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method |
12/24/2003 | CN1131855C 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy |
12/18/2003 | US20030232844 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2 mediated disorders |
12/11/2003 | WO2002092552A3 Benzamidoacetonitriles and their use as antiparasitics |
12/11/2003 | US20030229233 Process for the preparation of thioxanthones |
12/11/2003 | US20030229073 Tricyclic compounds and method of treating herpes virus |
12/11/2003 | US20030229054 Novel amines as pharmaceutical agents |
12/10/2003 | EP1368305A1 7, 9-substituted tetracycline compounds |
12/10/2003 | CN1461302A Friedel-craft process for preparation of thioxanthones |
12/04/2003 | WO2003099769A1 Anilino liver x-receptor modulators |
12/04/2003 | US20030225271 Compounds useful as reversible inhibitors of cysteine proteases |
12/04/2003 | US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
12/04/2003 | US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
12/04/2003 | CA2486644A1 Anilino liver x-receptor modulators |
12/03/2003 | EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
12/02/2003 | US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
11/27/2003 | WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
11/27/2003 | WO2002100813A3 Modulators of peroxisome proliferator activated receptors |
11/27/2003 | US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors |
11/26/2003 | EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
11/20/2003 | US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
11/20/2003 | US20030216383 Compounds useful as reversible inhibitors of cysteine proteases |
11/19/2003 | EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device |
11/19/2003 | EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
11/18/2003 | US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
11/13/2003 | US20030212061 Aza-thioxanthenones with antitumor activity |
11/12/2003 | CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity |
11/11/2003 | US6645951 Benzopyran or thiobenzopyran derivatives |
11/06/2003 | WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
11/06/2003 | WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient |
11/06/2003 | WO2003091189A1 Cannabinoids |
11/06/2003 | US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus |
11/06/2003 | US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET) |
11/06/2003 | US20030207201 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method |
11/06/2003 | CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
11/06/2003 | CA2483072A1 Cannabinoids |
11/05/2003 | EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity |
11/04/2003 | US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use |
10/30/2003 | US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase |
10/29/2003 | EP1089964B1 Hydrazine derivatives |
10/28/2003 | US6638685 Resolution, sensitivity and smoothness on side surfaces of a transferred pattern; photolithography |
10/23/2003 | WO2002046128A3 Quaternary amino acids on solid supports |
10/23/2003 | US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2 |
10/23/2003 | US20030198889 Sulfonium salt compounds represented by the following general formula (2) wherein R1 and R2 represent each an alkyl group optionally having oxo, or R1 and R2 may be cyclized together to form an alkylene group optionally having oxo group for |